| 查看: 1385 | 回復(fù): 14 | ||
lovelhw金蟲 (初入文壇)
|
[求助]
跪求幫我翻譯一下這段文字,職稱論文急需要
|
| 目的 觀察阿托伐他汀聯(lián)合阿斯匹林治療原發(fā)性高血壓合并頸動(dòng)脈粥樣硬化斑塊的療效。方法 存在頸動(dòng)脈粥樣硬化斑塊的原發(fā)性高血壓患者60例,隨機(jī)分為對(duì)照組組30例,給予單用阿斯匹林片,治療組30例,給予阿托伐他汀聯(lián)合阿斯匹林;治療前及治療后1、3、6月測(cè)定患者三酰甘油(TG)、血清總膽固醇(CH)、低密度脂蛋白膽固醇(LDL—C)、乳酸脫氫酶(LDH)和頸動(dòng)脈內(nèi)中膜厚度(IMT)、斑塊積分的變化。結(jié)果 治療6個(gè)月后三酰甘油(TG)、總膽固醇(TC)、血清總膽固醇(CH)、低密度脂蛋白膽固醇(LDL—C)、斑塊積分和頸動(dòng)脈內(nèi)中膜厚度(IMT)、分別為(2.05土0.9)mmol/L 結(jié)論 阿托伐他汀聯(lián)合阿斯匹林,對(duì)縮小頸動(dòng)脈粥樣斑塊體積、穩(wěn)定斑塊、降低血脂各項(xiàng)指標(biāo)有較好的效果,可作為原發(fā)性高血壓合并頸動(dòng)脈粥樣硬化斑塊治療的聯(lián)合藥物。 |
鐵桿木蟲 (正式寫手)

金蟲 (初入文壇)
|
阿托伐他汀Atorvastatin 阿斯匹林Aspirin 原發(fā)性高血壓primary hypertension 頸動(dòng)脈粥樣硬化斑塊Carotid atherosclerotic lesions 三酰甘油triglyceride 血清總膽固醇cholesteol 低密度脂蛋白膽固醇low density lipoprotein-cholesterol 乳酸脫氫酶lactate dehydrogenase 頸動(dòng)脈內(nèi)中膜厚度Intima-media thickness 斑塊積分crouse score 血脂blood fat 感激各位大俠。。 |
鐵桿木蟲 (正式寫手)
|
Objectives: To observe effectiveness of using atorvastatin in combination with aspirin for primary hypertension complicated by carotid atherosclerotic lesions. Methodology: The 60 patients of primary hypertension with carotid atherosclerotic lesions are randomly put into a control group of 30 patients who are prescribed aspirin only, and a treatment group of 30 patients who are prescribed atorvastatin and aspirin. Prior to the treatment and one, three and six months after it, the patients are tested for their TG, CH, LDL-C, LDH, IMT and crouse score, in particular the changes. Results: Six months after the treatment, all the TG, TC, CH, LDL-C, IMT values are (2.05土0.9)mmol/L Conclusions: Atorvastatin in combination with aspirin is effective for reducing volume of carotid atherosclerotic lesions, stabalising the crouse and reducing blood fat as well as other indices. Hence it can be used as a drug combination for treatment of primary hypertension with carotid atherosclerotic lesions. 結(jié)果一句: 原文說那些指標(biāo)都分別是 (2.05土0.9)mmol/L, 那么就是說它們都是 (2.05土0.9)mmol/L?還是它們分別是A, B, C,。。。請(qǐng)確認(rèn) 非本專業(yè),僅供參考 |

金蟲 (初入文壇)
鐵桿木蟲 (正式寫手)

金蟲 (初入文壇)
鐵桿木蟲 (正式寫手)
|
Results: Six months after the treatment, the TG, TC, CH, LDL-C, IMT values are (2.05±0.9)mmol/L, (5.21±1.3)mmol/L, (2.65±1.1)mmol/L, (4.01±1.35)mmol/L and (0.99±0.25)mm respectively,all lower than those of the control group: (2.59±1.2)mmol/L、(6.30±2.0)mmol/L、(3.20±1.2)mmol/L 、(4.98±1.73)mmol/L、(1.12±0.26)mm. 最后的一段話:(均P<O.05),有些疑惑。數(shù)字是0.05打錯(cuò)了嗎?均P<是什么意思? |

金蟲 (初入文壇)
鐵桿木蟲 (正式寫手)

| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 311求調(diào)劑 +3 | 冬十三 2026-03-18 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 295求調(diào)劑 +3 | 一志愿京區(qū)211 2026-03-18 | 5/250 |
|
|
[考研] 材料專業(yè)求調(diào)劑 +3 | hanamiko 2026-03-18 | 3/150 |
|
|
[考研] 化工學(xué)碩306求調(diào)劑 +10 | 42838695 2026-03-12 | 10/500 |
|
|
[考研] 一志愿985,本科211,0817化學(xué)工程與技術(shù)319求調(diào)劑 +6 | Liwangman 2026-03-15 | 6/300 |
|
|
[考研] 0703化學(xué)求調(diào)劑 總分331 +3 | ZY-05 2026-03-13 | 3/150 |
|
|
[考研] 材料專碩326求調(diào)劑 +6 | 墨煜姒莘 2026-03-15 | 7/350 |
|
|
[考研] 290求調(diào)劑 +3 | p asserby. 2026-03-15 | 4/200 |
|
|
[考研] 290求調(diào)劑 +6 | 孔志浩 2026-03-12 | 11/550 |
|
|
[考研] 285化工學(xué)碩求調(diào)劑(081700) +9 | 柴郡貓_ 2026-03-12 | 9/450 |
|
|
[考研] 326求調(diào)劑 +4 | 諾貝爾化學(xué)獎(jiǎng)覬?/a> 2026-03-15 | 7/350 |
|
|
[基金申請(qǐng)]
今年的國(guó)基金是打分制嗎?
50+3
|
zhanghaozhu 2026-03-14 | 3/150 |
|
|
[考研] 0703化學(xué)調(diào)劑 +6 | 妮妮ninicgb 2026-03-15 | 9/450 |
|
|
[考研] 0703一志愿211 285分求調(diào)劑 +5 | ly3471z 2026-03-13 | 5/250 |
|
|
[考研] 26考研一志愿中國(guó)石油大學(xué)(華東)305分求調(diào)劑 +3 | 嘉年新程 2026-03-15 | 3/150 |
|
|
[考研] 材料與化工 323 英一+數(shù)二+物化,一志愿:哈工大 本人本科雙一流 +4 | 自由的_飛翔 2026-03-13 | 5/250 |
|
|
[考研] 265求調(diào)劑 +4 | 威化餅07 2026-03-12 | 4/200 |
|
|
[基金申請(qǐng)] 現(xiàn)在如何回避去年的某一個(gè)專家,不知道名字 +3 | zk200107 2026-03-12 | 6/300 |
|
|
[考研] 復(fù)試調(diào)劑 +4 | z1z2z3879 2026-03-14 | 5/250 |
|
|
[考研] 266求調(diào)劑 +4 | 學(xué)員97LZgn 2026-03-13 | 4/200 |
|